Mediterrania Capital Partners (MCP), a leading private equity firm focused on growth investments in North and Sub-Saharan Africa, has announced a significant investment in Dislog Dispositifs Médicaux (DDM), the healthcare division of Morocco’s Dislog Group. The investment, totaling MAD 540 million (approximately USD 59 million), was made in partnership with CDG Invest Growth, marking a major milestone in the development of Morocco’s medical device sector.
This capital injection is aimed at propelling DDM’s ambition to become a comprehensive, one-stop provider of medical device solutions across a wide range of therapeutic areas. The company’s offerings span the design, manufacturing, and distribution of medical equipment, as well as technical support, engineering services, and maintenance—positioning it as a critical partner for healthcare professionals and institutions across the region.
Under the leadership of Moncef Belkhayat, Dislog Group has evolved into a powerhouse in Morocco’s fast-moving consumer goods (FMCG) industry, managing over 100 brands across food, health, and hygiene categories. DDM, its healthcare arm, is now poised to lead the next phase of growth by addressing the increasing demand for high-quality, locally available medical technologies.
Albert Alsina, Founder and CEO of Mediterrania Capital Partners, emphasized the strategic importance of the investment:
This investment in Dislog Dispositifs Médicaux reflects our continued commitment to supporting high-impact sectors across Africa. We are proud to join forces with a visionary entrepreneur like Moncef Belkhayat to help build a national and regional champion in medical devices.
Hatim Ben Ahmed, Managing Partner at MCP, added:
Following our recent investment in Dislog, we are very confident about this new venture. By implementing our value creation model, we aim to build a leading medical equipment platform through a buy-and-build strategy. This partnership is expected to deliver impact-driven returns while benefiting the Moroccan people by ensuring access to essential healthcare for all.
This investment follows MCP’s successful exit from Dislog Group after a 3.5-year partnership that saw the company’s annual revenues grow by 89%, reaching over €332 million. The exit underscores MCP’s ability to drive transformative growth and create long-term value in its portfolio companies. The new funding will enable DDM to scale its operations, invest in advanced technologies, and pursue strategic acquisitions—further strengthening Morocco’s position as a regional hub for medical innovation and manufacturing.
